Howard J. Weisman - 27 Oct 2023 Form 4 Insider Report for PaxMedica, Inc.

Signature
/s/ Stephen D. Sheldon, Jr. Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
27 Oct 2023
Net transactions value
-$1,524
Form type
4
Filing time
30 Oct 2023, 16:11:42 UTC
Previous filing
30 Aug 2023
Next filing
29 Nov 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PXMD Common Stock Sale $1,524 -8,049 -1.2% $0.1894 649,549 27 Oct 2023 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to the Reporting Person's pre-existing Rule 10b5-1 trading plan to, inter alia, pay tax withholding on vested RSUs.
F2 The sale price represents the weighted average sale price of the shares sold ranging from $0.1835 to $0.191 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3 Does not reflect a 1-for-17 reverse stock split effective October 30, 2023.